Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
51 hedge funds and large institutions have $207M invested in Aptose Biosciences, Inc. in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 22 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
100% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 9
19% more capital invested
Capital invested by funds: $174M → $207M (+$33.1M)
9% less funds holding
Funds holding: 56 → 51 (-5)
23% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 22
56% less call options, than puts
Call options by funds: $578K | Put options by funds: $1.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$16.9M |
| 2 |
CA
Corriente Advisors
Fort Worth,
Texas
|
+$16.3M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$10.5M |
| 4 |
CCM
Consonance Capital Management
New York
|
+$6.79M |
| 5 |
Goldman Sachs
New York
|
+$4.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5.72M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.51M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.37M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.65M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$3.45M |
APTO Hedge Fund Activity: Q1 2020 in Review
51 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q1 2020, worth a combined $207M — up 19% from $174M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of APTO and 17 opened new positions — a net loss of 5 holders — while 9 trimmed existing stakes and 18 added.
The largest buyer was Polar Capital, adding an estimated $16.9M. The largest seller was Ikarian Capital, exiting entirely with an estimated $5.72M sold.
- 51 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q1 2020, down from 56 in Q4 2019.
- Funds reported $207M of Aptose Biosciences, Inc. stock for Q1 2020, up 19% quarter-over-quarter.
- 17 funds opened new Aptose Biosciences, Inc. positions in Q1 2020 and 22 closed out, a net change of -5 holders.
- The largest Aptose Biosciences, Inc. buyer in Q1 2020 was Polar Capital, an estimated $16.9M added.
- The largest Aptose Biosciences, Inc. seller in Q1 2020 was Ikarian Capital, an estimated $5.72M sold.
Based on aggregated 13F filings for Q1 2020.